

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to peptidoglycan (GO:0032494) | 3.87974181 |
| 2 | protein localization to endosome (GO:0036010) | 3.70623726 |
| 3 | sodium ion export (GO:0071436) | 3.63943371 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.60449647 |
| 5 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.52967683 |
| 6 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.50212181 |
| 7 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.41991382 |
| 8 | activation of MAPKKK activity (GO:0000185) | 3.38900868 |
| 9 | NIK/NF-kappaB signaling (GO:0038061) | 3.35175885 |
| 10 | cytidine deamination (GO:0009972) | 3.28396207 |
| 11 | cytidine metabolic process (GO:0046087) | 3.28396207 |
| 12 | cytidine catabolic process (GO:0006216) | 3.28396207 |
| 13 | barbed-end actin filament capping (GO:0051016) | 3.27205108 |
| 14 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.24581903 |
| 15 | macrophage activation involved in immune response (GO:0002281) | 3.21608109 |
| 16 | epithelial cell-cell adhesion (GO:0090136) | 3.15900552 |
| 17 | negative regulation of interleukin-12 production (GO:0032695) | 3.13340283 |
| 18 | negative regulation of epidermal growth factor-activated receptor activity (GO:0007175) | 3.11669855 |
| 19 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.11169696 |
| 20 | modulation by symbiont of host cellular process (GO:0044068) | 3.09096397 |
| 21 | germinal center formation (GO:0002467) | 3.07211413 |
| 22 | chondrocyte proliferation (GO:0035988) | 3.05843216 |
| 23 | regulation of podosome assembly (GO:0071801) | 3.02365450 |
| 24 | glycosphingolipid catabolic process (GO:0046479) | 2.99707017 |
| 25 | plasma membrane repair (GO:0001778) | 2.98703804 |
| 26 | myeloid dendritic cell differentiation (GO:0043011) | 2.98531270 |
| 27 | response to muramyl dipeptide (GO:0032495) | 2.92997854 |
| 28 | adhesion of symbiont to host cell (GO:0044650) | 2.92873204 |
| 29 | virion attachment to host cell (GO:0019062) | 2.92873204 |
| 30 | regulation of early endosome to late endosome transport (GO:2000641) | 2.91322696 |
| 31 | regulation of p38MAPK cascade (GO:1900744) | 2.88951061 |
| 32 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.86581575 |
| 33 | apoptotic cell clearance (GO:0043277) | 2.85485299 |
| 34 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.84881065 |
| 35 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.76904770 |
| 36 | adhesion of symbiont to host (GO:0044406) | 2.76473920 |
| 37 | cellular potassium ion homeostasis (GO:0030007) | 2.75062372 |
| 38 | mannose metabolic process (GO:0006013) | 2.72255885 |
| 39 | stress fiber assembly (GO:0043149) | 2.69753759 |
| 40 | low-density lipoprotein particle clearance (GO:0034383) | 2.69495474 |
| 41 | growth hormone receptor signaling pathway (GO:0060396) | 2.69176555 |
| 42 | positive regulation of p38MAPK cascade (GO:1900745) | 2.68827466 |
| 43 | layer formation in cerebral cortex (GO:0021819) | 2.68558429 |
| 44 | bone resorption (GO:0045453) | 2.67345649 |
| 45 | glycolipid catabolic process (GO:0019377) | 2.67301286 |
| 46 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.66624398 |
| 47 | regulation of vitamin metabolic process (GO:0030656) | 2.62865025 |
| 48 | T-helper 1 type immune response (GO:0042088) | 2.62228496 |
| 49 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.61764165 |
| 50 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.59042802 |
| 51 | pinocytosis (GO:0006907) | 2.57543920 |
| 52 | neutrophil activation involved in immune response (GO:0002283) | 2.56820405 |
| 53 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.55432950 |
| 54 | cellular response to type I interferon (GO:0071357) | 2.55211552 |
| 55 | type I interferon signaling pathway (GO:0060337) | 2.55211552 |
| 56 | regulation of extracellular matrix disassembly (GO:0010715) | 2.55193542 |
| 57 | regulation of cholesterol homeostasis (GO:2000188) | 2.54725201 |
| 58 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.54600747 |
| 59 | cortical actin cytoskeleton organization (GO:0030866) | 2.53298589 |
| 60 | detection of other organism (GO:0098543) | 2.52993777 |
| 61 | positive regulation of extracellular matrix organization (GO:1903055) | 2.52920336 |
| 62 | response to type I interferon (GO:0034340) | 2.52898492 |
| 63 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.52656093 |
| 64 | positive regulation of histone deacetylation (GO:0031065) | 2.52497721 |
| 65 | negative regulation of fatty acid transport (GO:2000192) | 2.52391682 |
| 66 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.51222466 |
| 67 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.51131314 |
| 68 | regulation of ARF GTPase activity (GO:0032312) | 2.48029221 |
| 69 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.45466845 |
| 70 | immunoglobulin mediated immune response (GO:0016064) | 2.44689784 |
| 71 | detection of bacterium (GO:0016045) | 2.43903545 |
| 72 | regulation of leukocyte degranulation (GO:0043300) | 2.42679137 |
| 73 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.41746777 |
| 74 | oligosaccharide catabolic process (GO:0009313) | 2.41518165 |
| 75 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.41481724 |
| 76 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.38474395 |
| 77 | cellular response to virus (GO:0098586) | 2.37522389 |
| 78 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.37250414 |
| 79 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.36718438 |
| 80 | regulation of necrotic cell death (GO:0010939) | 2.36467540 |
| 81 | peptide catabolic process (GO:0043171) | 2.36248204 |
| 82 | myeloid dendritic cell activation (GO:0001773) | 2.35812984 |
| 83 | cellular response to growth hormone stimulus (GO:0071378) | 2.35350526 |
| 84 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.34981163 |
| 85 | semaphorin-plexin signaling pathway (GO:0071526) | 2.34695689 |
| 86 | negative regulation of cell killing (GO:0031342) | 2.34286651 |
| 87 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.34286651 |
| 88 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.34023590 |
| 89 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.33504436 |
| 90 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.33328444 |
| 91 | cell adhesion mediated by integrin (GO:0033627) | 2.33118898 |
| 92 | activation of protein kinase A activity (GO:0034199) | 2.33060542 |
| 93 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.32980143 |
| 94 | regulation of mononuclear cell migration (GO:0071675) | 2.32770837 |
| 95 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.31084920 |
| 96 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.30936421 |
| 97 | response to thyroid hormone (GO:0097066) | 2.30077154 |
| 98 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.29374667 |
| 99 | modulation by virus of host process (GO:0019054) | 2.29345493 |
| 100 | synaptic vesicle maturation (GO:0016188) | 2.29066991 |
| 101 | regulation of type 2 immune response (GO:0002828) | 2.28933654 |
| 102 | adherens junction assembly (GO:0034333) | 2.28899785 |
| 103 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.28443182 |
| 104 | heterochromatin organization (GO:0070828) | 2.27500672 |
| 105 | positive regulation of type 2 immune response (GO:0002830) | 2.27240685 |
| 106 | detection of molecule of bacterial origin (GO:0032490) | 2.27108739 |
| 107 | positive regulation of macrophage cytokine production (GO:0060907) | 2.26223008 |
| 108 | cell-substrate junction assembly (GO:0007044) | 2.25609277 |
| 109 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.25290276 |
| 110 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.25290276 |
| 111 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.25105060 |
| 112 | regulation of chemokine biosynthetic process (GO:0045073) | 2.24986776 |
| 113 | regulation of necroptotic process (GO:0060544) | 2.24795689 |
| 114 | regulation of superoxide anion generation (GO:0032928) | 2.24367711 |
| 115 | receptor catabolic process (GO:0032801) | 2.23768496 |
| 116 | detection of external biotic stimulus (GO:0098581) | 2.23697072 |
| 117 | potassium ion import (GO:0010107) | 2.23671511 |
| 118 | regulation of ARF protein signal transduction (GO:0032012) | 2.22883157 |
| 119 | hemidesmosome assembly (GO:0031581) | 2.22410887 |
| 120 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.21958403 |
| 121 | endocytic recycling (GO:0032456) | 2.21668077 |
| 122 | positive regulation of protein dephosphorylation (GO:0035307) | 2.21251824 |
| 123 | regulation of extracellular matrix organization (GO:1903053) | 2.20685446 |
| 124 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.20644013 |
| 125 | response to nerve growth factor (GO:1990089) | 2.20644013 |
| 126 | regulation of cholesterol storage (GO:0010885) | 2.20188404 |
| 127 | activation of JUN kinase activity (GO:0007257) | 2.19334364 |
| 128 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.17980140 |
| 129 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.17257096 |
| 130 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.17194868 |
| 131 | skin morphogenesis (GO:0043589) | 2.16799542 |
| 132 | protein retention in ER lumen (GO:0006621) | 2.16454838 |
| 133 | negative regulation of cell size (GO:0045792) | 2.16259865 |
| 134 | dendritic cell differentiation (GO:0097028) | 2.15308755 |
| 135 | positive regulation of receptor recycling (GO:0001921) | 2.15213986 |
| 136 | response to protozoan (GO:0001562) | 2.14261344 |
| 137 | response to laminar fluid shear stress (GO:0034616) | 2.13440621 |
| 138 | locomotory exploration behavior (GO:0035641) | 2.12727024 |
| 139 | extracellular matrix assembly (GO:0085029) | 2.12550789 |
| 140 | establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197) | 2.12515774 |
| 141 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.12193334 |
| 142 | nerve growth factor signaling pathway (GO:0038180) | 2.11729449 |
| 143 | macroautophagy (GO:0016236) | 2.11040323 |
| 144 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.10992232 |
| 145 | cortical cytoskeleton organization (GO:0030865) | 2.07929574 |
| 146 | regulation of macrophage cytokine production (GO:0010935) | 2.06007671 |
| 147 | positive regulation of protein export from nucleus (GO:0046827) | 2.04639057 |
| 148 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.03327801 |
| 149 | cell communication by electrical coupling (GO:0010644) | 2.02997122 |
| 150 | cellular sodium ion homeostasis (GO:0006883) | 2.01985403 |
| 151 | alkaloid metabolic process (GO:0009820) | 2.01217193 |
| 152 | cell communication involved in cardiac conduction (GO:0086065) | 2.00664671 |
| 153 | negative regulation of T cell differentiation in thymus (GO:0033085) | 2.00017450 |
| 154 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 1.98483920 |
| 155 | negative regulation of heart growth (GO:0061117) | 1.98483920 |
| 156 | positive regulation of JUN kinase activity (GO:0043507) | 1.97001001 |
| 157 | signal complex assembly (GO:0007172) | 1.96545654 |
| 158 | negative regulation of smooth muscle cell migration (GO:0014912) | 1.96290271 |
| 159 | sexual reproduction (GO:0019953) | 1.96041156 |
| 160 | positive regulation by symbiont of host defense response (GO:0052509) | 1.95944019 |
| 161 | modulation by symbiont of host defense response (GO:0052031) | 1.95944019 |
| 162 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 1.95944019 |
| 163 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 1.95944019 |
| 164 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 1.95944019 |
| 165 | modulation by symbiont of host immune response (GO:0052553) | 1.95944019 |
| 166 | antigen processing and presentation of endogenous antigen (GO:0019883) | 1.93340416 |
| 167 | cell-substrate adherens junction assembly (GO:0007045) | 1.90273345 |
| 168 | focal adhesion assembly (GO:0048041) | 1.90273345 |
| 169 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 1.90098865 |
| 170 | positive regulation of nuclease activity (GO:0032075) | 1.89930520 |
| 171 | maternal placenta development (GO:0001893) | 1.88586785 |
| 172 | blood vessel endothelial cell migration (GO:0043534) | 1.85922017 |
| 173 | negative regulation of nucleotide catabolic process (GO:0030812) | 1.85672700 |
| 174 | positive regulation of lamellipodium assembly (GO:0010592) | 1.84873071 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.94481164 |
| 2 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 3.04988799 |
| 3 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.46658265 |
| 4 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.31141552 |
| 5 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.10040019 |
| 6 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.08820628 |
| 7 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.01224355 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.00579806 |
| 9 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.94463350 |
| 10 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.93991518 |
| 11 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.90047046 |
| 12 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.89621637 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.89555697 |
| 14 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.85021514 |
| 15 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.82690275 |
| 16 | KDM2B_26808549_Chip-Seq_K562_Human | 1.82504327 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.81081463 |
| 18 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.77507590 |
| 19 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.74544308 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.71673088 |
| 21 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.68897771 |
| 22 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.66237859 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.63970357 |
| 24 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.63387901 |
| 25 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.63248193 |
| 26 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.60701950 |
| 27 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.59532224 |
| 28 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.58755656 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.58375880 |
| 30 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.58306421 |
| 31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54610721 |
| 32 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.54569647 |
| 33 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.49835697 |
| 34 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.48374106 |
| 35 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.47956536 |
| 36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47192962 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.46099189 |
| 38 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.44984130 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.44802316 |
| 40 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.44376156 |
| 41 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.42972683 |
| 42 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.41340608 |
| 43 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.40402035 |
| 44 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.39922686 |
| 45 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.36400463 |
| 46 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34255970 |
| 47 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.33959544 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.33852091 |
| 49 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.33064450 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.32485833 |
| 51 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.31588054 |
| 52 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.30373230 |
| 53 | ATF3_27146783_Chip-Seq_COLON_Human | 1.29834501 |
| 54 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29457072 |
| 55 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.29226156 |
| 56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.29006740 |
| 57 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26690974 |
| 58 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26517968 |
| 59 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.25850229 |
| 60 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25295669 |
| 61 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25277604 |
| 62 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23770169 |
| 63 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23063235 |
| 64 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.23020175 |
| 65 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22746315 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.21724736 |
| 67 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21592922 |
| 68 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.21343786 |
| 69 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20508345 |
| 70 | MYC_22102868_ChIP-Seq_BL_Human | 1.18935336 |
| 71 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.18782508 |
| 72 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.18683445 |
| 73 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.18438598 |
| 74 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.18249715 |
| 75 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.17940576 |
| 76 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.17612356 |
| 77 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.16117902 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.15826524 |
| 79 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14739230 |
| 80 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.14319285 |
| 81 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.13325512 |
| 82 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.12802601 |
| 83 | RXR_22108803_ChIP-Seq_LS180_Human | 1.12457306 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12430347 |
| 85 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.12427090 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12389956 |
| 87 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.09703383 |
| 88 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.09676173 |
| 89 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09395693 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08957608 |
| 91 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08863981 |
| 92 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.08539325 |
| 93 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07999409 |
| 94 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.07777225 |
| 95 | MAF_26560356_Chip-Seq_TH2_Human | 1.07753388 |
| 96 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.07113623 |
| 97 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07108672 |
| 98 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05377673 |
| 99 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.05138655 |
| 100 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05006924 |
| 101 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04927001 |
| 102 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03971015 |
| 103 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.03440345 |
| 104 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.03423761 |
| 105 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.02567533 |
| 106 | SPI1_23127762_ChIP-Seq_K562_Human | 1.02279180 |
| 107 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02088572 |
| 108 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01389028 |
| 109 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01389028 |
| 110 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01358485 |
| 111 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.00914653 |
| 112 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00075283 |
| 113 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.99991015 |
| 114 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.99846227 |
| 115 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.99416357 |
| 116 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.99042336 |
| 117 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.98799366 |
| 118 | P68_20966046_ChIP-Seq_HELA_Human | 0.97668793 |
| 119 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.97512130 |
| 120 | GATA2_19941826_ChIP-Seq_K562_Human | 0.97386816 |
| 121 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.97363628 |
| 122 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96910142 |
| 123 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.96238722 |
| 124 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95866976 |
| 125 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.95692171 |
| 126 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.95616529 |
| 127 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.95327454 |
| 128 | UTX_26944678_Chip-Seq_JUKART_Human | 0.92630991 |
| 129 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.92046334 |
| 130 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91986105 |
| 131 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91982846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 6.23152808 |
| 2 | MP0003283_abnormal_digestive_organ | 4.82903969 |
| 3 | MP0003705_abnormal_hypodermis_morpholog | 3.96928477 |
| 4 | MP0003566_abnormal_cell_adhesion | 3.17289359 |
| 5 | MP0003303_peritoneal_inflammation | 3.06511772 |
| 6 | MP0005451_abnormal_body_composition | 2.84927417 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.84007258 |
| 8 | MP0002234_abnormal_pharynx_morphology | 2.45296821 |
| 9 | MP0005058_abnormal_lysosome_morphology | 2.34585731 |
| 10 | MP0004510_myositis | 2.25189894 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.14590822 |
| 12 | MP0003045_fibrosis | 2.12543526 |
| 13 | MP0003724_increased_susceptibility_to | 2.01828568 |
| 14 | MP0008438_abnormal_cutaneous_collagen | 1.97124544 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 1.96248960 |
| 16 | MP0004859_abnormal_synaptic_plasticity | 1.95836990 |
| 17 | MP0009053_abnormal_anal_canal | 1.93966189 |
| 18 | MP0009785_altered_susceptibility_to | 1.93818516 |
| 19 | MP0002139_abnormal_hepatobiliary_system | 1.92091460 |
| 20 | MP0004858_abnormal_nervous_system | 1.91164313 |
| 21 | MP0002419_abnormal_innate_immunity | 1.90059048 |
| 22 | MP0005025_abnormal_response_to | 1.88147769 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.83885672 |
| 24 | MP0005275_abnormal_skin_tensile | 1.79593551 |
| 25 | MP0008961_abnormal_basal_metabolism | 1.78702530 |
| 26 | MP0004947_skin_inflammation | 1.75100400 |
| 27 | MP0000858_altered_metastatic_potential | 1.75016629 |
| 28 | MP0001835_abnormal_antigen_presentation | 1.74389235 |
| 29 | MP0005623_abnormal_meninges_morphology | 1.69991486 |
| 30 | MP0008260_abnormal_autophagy | 1.64935838 |
| 31 | MP0003329_amyloid_beta_deposits | 1.64127533 |
| 32 | MP0002877_abnormal_melanocyte_morpholog | 1.58338336 |
| 33 | MP0000604_amyloidosis | 1.57478247 |
| 34 | MP0008004_abnormal_stomach_pH | 1.56635374 |
| 35 | MP0002796_impaired_skin_barrier | 1.54684346 |
| 36 | MP0005076_abnormal_cell_differentiation | 1.54322223 |
| 37 | MP0005167_abnormal_blood-brain_barrier | 1.51432229 |
| 38 | MP0003075_altered_response_to | 1.47592511 |
| 39 | MP0004130_abnormal_muscle_cell | 1.46816043 |
| 40 | MP0002452_abnormal_antigen_presenting | 1.41314267 |
| 41 | MP0004272_abnormal_basement_membrane | 1.38521860 |
| 42 | MP0002723_abnormal_immune_serum | 1.36947153 |
| 43 | MP0003091_abnormal_cell_migration | 1.36569894 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.33706080 |
| 45 | MP0001853_heart_inflammation | 1.33428980 |
| 46 | MP0003453_abnormal_keratinocyte_physiol | 1.32317328 |
| 47 | MP0009840_abnormal_foam_cell | 1.32109767 |
| 48 | MP0010352_gastrointestinal_tract_polyps | 1.31978701 |
| 49 | MP0001800_abnormal_humoral_immune | 1.30070316 |
| 50 | MP0001958_emphysema | 1.29482762 |
| 51 | MP0003172_abnormal_lysosome_physiology | 1.29431144 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.25471784 |
| 53 | MP0010678_abnormal_skin_adnexa | 1.20836284 |
| 54 | MP0002909_abnormal_adrenal_gland | 1.20629659 |
| 55 | MP0001819_abnormal_immune_cell | 1.20278088 |
| 56 | MP0000751_myopathy | 1.19968628 |
| 57 | MP0002420_abnormal_adaptive_immunity | 1.19947711 |
| 58 | MP0009333_abnormal_splenocyte_physiolog | 1.19460771 |
| 59 | MP0009764_decreased_sensitivity_to | 1.15865704 |
| 60 | MP0001849_ear_inflammation | 1.15259586 |
| 61 | MP0009780_abnormal_chondrocyte_physiolo | 1.14832093 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.13733089 |
| 63 | MP0005671_abnormal_response_to | 1.13598101 |
| 64 | MP0008469_abnormal_protein_level | 1.09281525 |
| 65 | MP0003436_decreased_susceptibility_to | 1.08768369 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.08271119 |
| 67 | MP0000569_abnormal_digit_pigmentation | 1.08190883 |
| 68 | MP0002896_abnormal_bone_mineralization | 1.06196663 |
| 69 | MP0002405_respiratory_system_inflammati | 1.05582521 |
| 70 | MP0000733_abnormal_muscle_development | 1.05387828 |
| 71 | MP0005409_darkened_coat_color | 1.04220768 |
| 72 | MP0005375_adipose_tissue_phenotype | 1.03539509 |
| 73 | MP0001666_abnormal_nutrient_absorption | 1.01114821 |
| 74 | MP0004264_abnormal_extraembryonic_tissu | 1.00690635 |
| 75 | MP0005166_decreased_susceptibility_to | 0.99935331 |
| 76 | MP0005165_increased_susceptibility_to | 0.99670664 |
| 77 | MP0004087_abnormal_muscle_fiber | 0.98878011 |
| 78 | MP0003828_pulmonary_edema | 0.97359140 |
| 79 | MP0005083_abnormal_biliary_tract | 0.96217772 |
| 80 | MP0003690_abnormal_glial_cell | 0.96199235 |
| 81 | MP0003866_abnormal_defecation | 0.95956042 |
| 82 | MP0000920_abnormal_myelination | 0.94602330 |
| 83 | MP0005023_abnormal_wound_healing | 0.94286853 |
| 84 | MP0005390_skeleton_phenotype | 0.91124511 |
| 85 | MP0002089_abnormal_postnatal_growth/wei | 0.90864120 |
| 86 | MP0003879_abnormal_hair_cell | 0.90389501 |
| 87 | MP0003279_aneurysm | 0.90372599 |
| 88 | MP0002254_reproductive_system_inflammat | 0.89688939 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.88985051 |
| 90 | MP0003634_abnormal_glial_cell | 0.87593931 |
| 91 | MP0001545_abnormal_hematopoietic_system | 0.87319402 |
| 92 | MP0005397_hematopoietic_system_phenotyp | 0.87319402 |
| 93 | MP0009278_abnormal_bone_marrow | 0.86942158 |
| 94 | MP0001663_abnormal_digestive_system | 0.86091791 |
| 95 | MP0000747_muscle_weakness | 0.85904730 |
| 96 | MP0001501_abnormal_sleep_pattern | 0.85630710 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.84827422 |
| 98 | MP0000716_abnormal_immune_system | 0.84306424 |
| 99 | MP0006082_CNS_inflammation | 0.84185299 |
| 100 | MP0000678_abnormal_parathyroid_gland | 0.84161323 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.83524889 |
| 102 | MP0005310_abnormal_salivary_gland | 0.81964554 |
| 103 | MP0000490_abnormal_crypts_of | 0.81390474 |
| 104 | MP0005164_abnormal_response_to | 0.80995118 |
| 105 | MP0001756_abnormal_urination | 0.80412440 |
| 106 | MP0001348_abnormal_lacrimal_gland | 0.79732451 |
| 107 | MP0004084_abnormal_cardiac_muscle | 0.79350044 |
| 108 | MP0008569_lethality_at_weaning | 0.79205919 |
| 109 | MP0003448_altered_tumor_morphology | 0.79059872 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.78620512 |
| 111 | MP0002332_abnormal_exercise_endurance | 0.75739921 |
| 112 | MP0000013_abnormal_adipose_tissue | 0.74847980 |
| 113 | MP0000462_abnormal_digestive_system | 0.72718094 |
| 114 | MP0001542_abnormal_bone_strength | 0.72587312 |
| 115 | MP0003763_abnormal_thymus_physiology | 0.71039857 |
| 116 | MP0005387_immune_system_phenotype | 0.70635936 |
| 117 | MP0001790_abnormal_immune_system | 0.70635936 |
| 118 | MP0002398_abnormal_bone_marrow | 0.69050624 |
| 119 | MP0001881_abnormal_mammary_gland | 0.68954550 |
| 120 | MP0000750_abnormal_muscle_regeneration | 0.68945198 |
| 121 | MP0005381_digestive/alimentary_phenotyp | 0.68554568 |
| 122 | MP0005501_abnormal_skin_physiology | 0.66505970 |
| 123 | MP0000003_abnormal_adipose_tissue | 0.65424251 |
| 124 | MP0000534_abnormal_ureter_morphology | 0.65064694 |
| 125 | MP0000377_abnormal_hair_follicle | 0.64683230 |
| 126 | MP0002168_other_aberrant_phenotype | 0.64570741 |
| 127 | MP0000685_abnormal_immune_system | 0.64455760 |
| 128 | MP0010630_abnormal_cardiac_muscle | 0.64291279 |
| 129 | MP0003252_abnormal_bile_duct | 0.63675645 |
| 130 | MP0003795_abnormal_bone_structure | 0.62354143 |
| 131 | MP0010155_abnormal_intestine_physiology | 0.61116973 |
| 132 | MP0000343_altered_response_to | 0.60325529 |
| 133 | MP0000767_abnormal_smooth_muscle | 0.60296464 |
| 134 | MP0008775_abnormal_heart_ventricle | 0.60018640 |
| 135 | MP0005464_abnormal_platelet_physiology | 0.59817898 |
| 136 | MP0003385_abnormal_body_wall | 0.59345125 |
| 137 | MP0005257_abnormal_intraocular_pressure | 0.59287823 |
| 138 | MP0001216_abnormal_epidermal_layer | 0.59208274 |
| 139 | MP0009643_abnormal_urine_homeostasis | 0.58933642 |
| 140 | MP0002282_abnormal_trachea_morphology | 0.58281406 |
| 141 | MP0008874_decreased_physiological_sensi | 0.58179948 |
| 142 | MP0006054_spinal_hemorrhage | 0.57607779 |
| 143 | MP0002837_dystrophic_cardiac_calcinosis | 0.57354191 |
| 144 | MP0010329_abnormal_lipoprotein_level | 0.56351461 |
| 145 | MP0003635_abnormal_synaptic_transmissio | 0.55965313 |
| 146 | MP0002090_abnormal_vision | 0.55826379 |
| 147 | MP0001851_eye_inflammation | 0.53826018 |
| 148 | MP0004036_abnormal_muscle_relaxation | 0.52422084 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.26078029 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.26078029 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 4.26078029 |
| 4 | Flat acetabular roof (HP:0003180) | 4.00828987 |
| 5 | Neonatal short-limb short stature (HP:0008921) | 3.92179198 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 3.59493417 |
| 7 | Abnormality of macrophages (HP:0004311) | 3.31579555 |
| 8 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 3.13926835 |
| 9 | Nuclear cataract (HP:0100018) | 3.12866319 |
| 10 | Axonal loss (HP:0003447) | 3.04303825 |
| 11 | Cerebral aneurysm (HP:0004944) | 3.02705285 |
| 12 | Loss of speech (HP:0002371) | 2.91284472 |
| 13 | Spinal cord compression (HP:0002176) | 2.86939482 |
| 14 | Cupped ribs (HP:0000887) | 2.73198818 |
| 15 | Large earlobe (HP:0009748) | 2.73035703 |
| 16 | Disinhibition (HP:0000734) | 2.68271905 |
| 17 | Abnormal cartilage morphology (HP:0002763) | 2.65600760 |
| 18 | Visceral angiomatosis (HP:0100761) | 2.65446292 |
| 19 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 2.61957263 |
| 20 | Vertebral compression fractures (HP:0002953) | 2.59218514 |
| 21 | Amyloidosis (HP:0011034) | 2.58640794 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 2.54432557 |
| 23 | Hyperparathyroidism (HP:0000843) | 2.53631899 |
| 24 | Achilles tendon contracture (HP:0001771) | 2.50530088 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.49260714 |
| 26 | Hemangiomatosis (HP:0007461) | 2.47897736 |
| 27 | Abnormality of the 1st metacarpal (HP:0010009) | 2.46800367 |
| 28 | Recurrent abscess formation (HP:0002722) | 2.46698786 |
| 29 | Vertebral hypoplasia (HP:0008417) | 2.45781621 |
| 30 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.45781621 |
| 31 | Vacuolated lymphocytes (HP:0001922) | 2.43973860 |
| 32 | Apathy (HP:0000741) | 2.42489724 |
| 33 | Neuronal loss in central nervous system (HP:0002529) | 2.40485926 |
| 34 | Flattened epiphyses (HP:0003071) | 2.40412437 |
| 35 | Dysostosis multiplex (HP:0000943) | 2.40098791 |
| 36 | Increased cerebral lipofuscin (HP:0011813) | 2.39050923 |
| 37 | Orchitis (HP:0100796) | 2.38712377 |
| 38 | Vertebral clefting (HP:0008428) | 2.37080937 |
| 39 | Distal lower limb muscle weakness (HP:0009053) | 2.36719992 |
| 40 | Hyporeflexia of lower limbs (HP:0002600) | 2.36650944 |
| 41 | Glomerulonephritis (HP:0000099) | 2.35910428 |
| 42 | Malnutrition (HP:0004395) | 2.35119170 |
| 43 | Abnormality of the Achilles tendon (HP:0005109) | 2.34401311 |
| 44 | Protrusio acetabuli (HP:0003179) | 2.32012631 |
| 45 | Diminished motivation (HP:0000745) | 2.31216941 |
| 46 | Upper limb amyotrophy (HP:0009129) | 2.30601425 |
| 47 | Distal upper limb amyotrophy (HP:0007149) | 2.30601425 |
| 48 | Coronal craniosynostosis (HP:0004440) | 2.29223391 |
| 49 | Right ventricular cardiomyopathy (HP:0011663) | 2.23972652 |
| 50 | Distal lower limb amyotrophy (HP:0008944) | 2.21957298 |
| 51 | Abnormality of complement system (HP:0005339) | 2.21864066 |
| 52 | Genu recurvatum (HP:0002816) | 2.21383279 |
| 53 | Myositis (HP:0100614) | 2.20656285 |
| 54 | Abnormality of the nasal mucosa (HP:0000433) | 2.20466660 |
| 55 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.19864978 |
| 56 | Cerebral inclusion bodies (HP:0100314) | 2.18865131 |
| 57 | Breech presentation (HP:0001623) | 2.17491993 |
| 58 | Shallow orbits (HP:0000586) | 2.15706825 |
| 59 | Gastrointestinal stroma tumor (HP:0100723) | 2.15466149 |
| 60 | Abnormal vertebral ossification (HP:0100569) | 2.15349070 |
| 61 | Mitral valve prolapse (HP:0001634) | 2.14590979 |
| 62 | Premature rupture of membranes (HP:0001788) | 2.14532420 |
| 63 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14467559 |
| 64 | Fragile nails (HP:0001808) | 2.13293110 |
| 65 | Increased IgE level (HP:0003212) | 2.13190666 |
| 66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.12478367 |
| 67 | Mediastinal lymphadenopathy (HP:0100721) | 2.10282606 |
| 68 | Purpura (HP:0000979) | 2.09463701 |
| 69 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 2.05762679 |
| 70 | Hip contracture (HP:0003273) | 2.05487732 |
| 71 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.05373712 |
| 72 | Lumbar hyperlordosis (HP:0002938) | 2.05304495 |
| 73 | Frequent falls (HP:0002359) | 2.04155725 |
| 74 | Supranuclear gaze palsy (HP:0000605) | 2.04146311 |
| 75 | Polygenic inheritance (HP:0010982) | 2.03082642 |
| 76 | Megalencephaly (HP:0001355) | 2.02955249 |
| 77 | Hemorrhage of the eye (HP:0011885) | 2.02675366 |
| 78 | Eczematoid dermatitis (HP:0000976) | 2.02348443 |
| 79 | Obstructive sleep apnea (HP:0002870) | 2.02337964 |
| 80 | Complement deficiency (HP:0004431) | 2.01771117 |
| 81 | Bone pain (HP:0002653) | 2.00475971 |
| 82 | Cellulitis (HP:0100658) | 1.98520893 |
| 83 | Difficulty running (HP:0009046) | 1.98120605 |
| 84 | Exercise-induced muscle cramps (HP:0003710) | 1.97595303 |
| 85 | Mutism (HP:0002300) | 1.96970511 |
| 86 | Mucopolysacchariduria (HP:0008155) | 1.96885513 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.96885513 |
| 88 | Flat capital femoral epiphysis (HP:0003370) | 1.95460485 |
| 89 | Tracheal stenosis (HP:0002777) | 1.95311926 |
| 90 | Peritonitis (HP:0002586) | 1.94902263 |
| 91 | Hyperextensible skin (HP:0000974) | 1.94372655 |
| 92 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.92865576 |
| 93 | Retrobulbar optic neuritis (HP:0100654) | 1.92803440 |
| 94 | Optic neuritis (HP:0100653) | 1.92803440 |
| 95 | Gingivitis (HP:0000230) | 1.91672313 |
| 96 | Ovoid vertebral bodies (HP:0003300) | 1.91546328 |
| 97 | Increased variability in muscle fiber diameter (HP:0003557) | 1.90556275 |
| 98 | Increased connective tissue (HP:0009025) | 1.90407901 |
| 99 | Emphysema (HP:0002097) | 1.89939585 |
| 100 | Hand muscle atrophy (HP:0009130) | 1.89364928 |
| 101 | Short phalanx of the thumb (HP:0009660) | 1.89234043 |
| 102 | Absent phalangeal crease (HP:0006109) | 1.88412156 |
| 103 | Increased serum ferritin (HP:0003281) | 1.87810780 |
| 104 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.87527231 |
| 105 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.87527231 |
| 106 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.87527231 |
| 107 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.87362420 |
| 108 | Asymmetric septal hypertrophy (HP:0001670) | 1.86906899 |
| 109 | Pathologic fracture (HP:0002756) | 1.86813715 |
| 110 | Broad metatarsal (HP:0001783) | 1.86569284 |
| 111 | Myocardial infarction (HP:0001658) | 1.86159961 |
| 112 | Ulnar bowing (HP:0003031) | 1.85904585 |
| 113 | Nasal polyposis (HP:0100582) | 1.85497116 |
| 114 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.85335310 |
| 115 | Upper motor neuron abnormality (HP:0002127) | 1.81838140 |
| 116 | Type 1 muscle fiber predominance (HP:0003803) | 1.80802968 |
| 117 | Dilatation of the ascending aorta (HP:0005111) | 1.79002130 |
| 118 | Deep venous thrombosis (HP:0002625) | 1.78869180 |
| 119 | Short hallux (HP:0010109) | 1.78732870 |
| 120 | Exercise-induced myalgia (HP:0003738) | 1.78346502 |
| 121 | Atrophic scars (HP:0001075) | 1.76577464 |
| 122 | Dementia (HP:0000726) | 1.76435273 |
| 123 | Woolly hair (HP:0002224) | 1.75185505 |
| 124 | Personality changes (HP:0000751) | 1.74755034 |
| 125 | Interstitial pulmonary disease (HP:0006530) | 1.74741512 |
| 126 | Thoracic kyphosis (HP:0002942) | 1.74700380 |
| 127 | Abnormality of carpal bone ossification (HP:0006257) | 1.74421531 |
| 128 | Abnormality of the 2nd finger (HP:0004100) | 1.74388486 |
| 129 | Difficulty climbing stairs (HP:0003551) | 1.74275195 |
| 130 | Short middle phalanx of finger (HP:0005819) | 1.73714549 |
| 131 | Obstructive lung disease (HP:0006536) | 1.73560259 |
| 132 | Chronic obstructive pulmonary disease (HP:0006510) | 1.73560259 |
| 133 | Aneurysm (HP:0002617) | 1.73388439 |
| 134 | Abnormal ossification of hand bones (HP:0005921) | 1.72561549 |
| 135 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.72496127 |
| 136 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.71530755 |
| 137 | Hypercortisolism (HP:0001578) | 1.70483157 |
| 138 | Vasculitis (HP:0002633) | 1.70426926 |
| 139 | Rapidly progressive (HP:0003678) | 1.68156416 |
| 140 | Aortic aneurysm (HP:0004942) | 1.67977128 |
| 141 | Abnormality of the thoracic spine (HP:0100711) | 1.67707500 |
| 142 | Broad face (HP:0000283) | 1.67664951 |
| 143 | Ulnar deviation of finger (HP:0009465) | 1.67566597 |
| 144 | Intellectual disability, profound (HP:0002187) | 1.66699229 |
| 145 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 1.66662087 |
| 146 | Neurofibrillary tangles (HP:0002185) | 1.66353781 |
| 147 | Thin bony cortex (HP:0002753) | 1.66132418 |
| 148 | Progressive neurologic deterioration (HP:0002344) | 1.65808733 |
| 149 | Asymmetric growth (HP:0100555) | 1.65291997 |
| 150 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 1.65223756 |
| 151 | Increased density of long bones (HP:0006392) | 1.65018688 |
| 152 | Restrictive lung disease (HP:0002091) | 1.64653169 |
| 153 | Broad palm (HP:0001169) | 1.64503634 |
| 154 | Hyperacusis (HP:0010780) | 1.64039743 |
| 155 | Aortic dissection (HP:0002647) | 1.63221630 |
| 156 | Bulbar palsy (HP:0001283) | 1.62850397 |
| 157 | Subacute progressive viral hepatitis (HP:0006572) | 1.62306235 |
| 158 | Striae distensae (HP:0001065) | 1.62248506 |
| 159 | Turricephaly (HP:0000262) | 1.60438644 |
| 160 | Hip dysplasia (HP:0001385) | 1.60433157 |
| 161 | Scapular winging (HP:0003691) | 1.60395767 |
| 162 | Abnormality of the acetabulum (HP:0003170) | 1.59897088 |
| 163 | Increased CSF protein (HP:0002922) | 1.59084036 |
| 164 | Slow saccadic eye movements (HP:0000514) | 1.57116920 |
| 165 | Urticaria (HP:0001025) | 1.56384742 |
| 166 | Spontaneous hematomas (HP:0007420) | 1.56024270 |
| 167 | Multiple lipomas (HP:0001012) | 1.55217985 |
| 168 | Lower limb amyotrophy (HP:0007210) | 1.54978402 |
| 169 | Mitral regurgitation (HP:0001653) | 1.54883827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 8.56922887 |
| 2 | TRIB3 | 3.94127593 |
| 3 | IRAK3 | 3.65378142 |
| 4 | PRPF4B | 3.42988990 |
| 5 | EPHB2 | 2.97288918 |
| 6 | RIPK1 | 2.92238494 |
| 7 | PKN2 | 2.72825231 |
| 8 | MAP3K9 | 2.51609129 |
| 9 | KSR2 | 2.45888258 |
| 10 | NME2 | 2.39584961 |
| 11 | TAOK2 | 2.05661304 |
| 12 | TTN | 1.89333504 |
| 13 | PTK6 | 1.87768365 |
| 14 | ERN1 | 1.76336522 |
| 15 | EEF2K | 1.76178603 |
| 16 | SMG1 | 1.76012082 |
| 17 | TAOK1 | 1.73013924 |
| 18 | EPHB1 | 1.70112476 |
| 19 | MAP3K3 | 1.65625493 |
| 20 | EPHA2 | 1.62382133 |
| 21 | ICK | 1.59807573 |
| 22 | MAP2K3 | 1.57669654 |
| 23 | BMX | 1.50274974 |
| 24 | IRAK4 | 1.49020420 |
| 25 | MAP3K2 | 1.47532865 |
| 26 | CDC42BPA | 1.40540022 |
| 27 | PDGFRA | 1.27843413 |
| 28 | MAP3K10 | 1.27552174 |
| 29 | MAP3K13 | 1.25305847 |
| 30 | RIPK4 | 1.24043411 |
| 31 | ALK | 1.23308783 |
| 32 | DDR2 | 1.22616865 |
| 33 | BLK | 1.16356885 |
| 34 | LRRK2 | 1.11774713 |
| 35 | GRK6 | 1.10592718 |
| 36 | RET | 1.10001385 |
| 37 | PTK2 | 1.09107126 |
| 38 | ZAP70 | 1.07738063 |
| 39 | CAMKK1 | 1.03983681 |
| 40 | DMPK | 1.03166847 |
| 41 | ILK | 1.01742639 |
| 42 | TGFBR2 | 0.98023064 |
| 43 | MATK | 0.97229776 |
| 44 | PAK6 | 0.96827023 |
| 45 | IRAK2 | 0.94218520 |
| 46 | FGFR4 | 0.92202933 |
| 47 | PRKD3 | 0.91108870 |
| 48 | MAP3K1 | 0.90429482 |
| 49 | LMTK2 | 0.90221172 |
| 50 | TYRO3 | 0.89801656 |
| 51 | NTRK1 | 0.86196859 |
| 52 | CAMK1G | 0.85316941 |
| 53 | SIK1 | 0.82106025 |
| 54 | PIM2 | 0.81639012 |
| 55 | PTK2B | 0.80319812 |
| 56 | SIK3 | 0.80069265 |
| 57 | ARAF | 0.77765098 |
| 58 | JAK1 | 0.75344647 |
| 59 | PAK4 | 0.74908960 |
| 60 | GRK7 | 0.74347318 |
| 61 | PRKCH | 0.74327519 |
| 62 | TBK1 | 0.73477989 |
| 63 | SCYL2 | 0.73254159 |
| 64 | IKBKE | 0.73178140 |
| 65 | TESK2 | 0.72995313 |
| 66 | SIK2 | 0.72970383 |
| 67 | FER | 0.71848382 |
| 68 | FGR | 0.71356324 |
| 69 | MAP2K2 | 0.70866688 |
| 70 | JAK3 | 0.70033464 |
| 71 | PDGFRB | 0.67637591 |
| 72 | MAP2K1 | 0.67124458 |
| 73 | JAK2 | 0.65846735 |
| 74 | CSK | 0.65659080 |
| 75 | IKBKB | 0.64150559 |
| 76 | ABL2 | 0.64119872 |
| 77 | PDPK1 | 0.63923609 |
| 78 | HIPK2 | 0.61493865 |
| 79 | RPS6KA2 | 0.61413459 |
| 80 | DAPK2 | 0.61172253 |
| 81 | PRKG2 | 0.60394649 |
| 82 | MAP3K7 | 0.59990039 |
| 83 | FGFR3 | 0.58800845 |
| 84 | MST1R | 0.57968062 |
| 85 | PDK1 | 0.56349555 |
| 86 | MAP4K1 | 0.55835570 |
| 87 | MOS | 0.55707069 |
| 88 | LATS2 | 0.53909541 |
| 89 | STK11 | 0.53467406 |
| 90 | MAP3K14 | 0.53237395 |
| 91 | RPS6KC1 | 0.53138892 |
| 92 | RPS6KL1 | 0.53138892 |
| 93 | FES | 0.53070624 |
| 94 | BRAF | 0.52371299 |
| 95 | PAK3 | 0.51634589 |
| 96 | CAMK1D | 0.51407479 |
| 97 | PRKD1 | 0.51027080 |
| 98 | MAPK12 | 0.50596936 |
| 99 | CHUK | 0.49324043 |
| 100 | CSF1R | 0.48790851 |
| 101 | PAK2 | 0.48770732 |
| 102 | KSR1 | 0.47330164 |
| 103 | FGFR1 | 0.47173431 |
| 104 | STK38 | 0.47046333 |
| 105 | MTOR | 0.46936043 |
| 106 | DYRK1B | 0.46789036 |
| 107 | MAPK7 | 0.46575923 |
| 108 | TYK2 | 0.46285985 |
| 109 | SGK3 | 0.45808034 |
| 110 | STK24 | 0.45420207 |
| 111 | NEK9 | 0.45319084 |
| 112 | PHKG1 | 0.44265075 |
| 113 | PHKG2 | 0.44265075 |
| 114 | TESK1 | 0.43995221 |
| 115 | SRC | 0.43266208 |
| 116 | STK10 | 0.43126981 |
| 117 | MAPK11 | 0.42296953 |
| 118 | CDK6 | 0.42073640 |
| 119 | EPHA3 | 0.41058047 |
| 120 | DAPK3 | 0.40656566 |
| 121 | HCK | 0.40643967 |
| 122 | MAP3K6 | 0.40034295 |
| 123 | IRAK1 | 0.38290278 |
| 124 | PRKD2 | 0.38281118 |
| 125 | EGFR | 0.37283485 |
| 126 | ROCK2 | 0.36126123 |
| 127 | MAP3K8 | 0.35971692 |
| 128 | NTRK3 | 0.35658893 |
| 129 | ITK | 0.35487752 |
| 130 | WNK1 | 0.34646700 |
| 131 | CDK5 | 0.33384177 |
| 132 | FYN | 0.30280411 |
| 133 | RAF1 | 0.30258879 |
| 134 | MINK1 | 0.28563284 |
| 135 | MARK2 | 0.27668903 |
| 136 | RPS6KA1 | 0.27531590 |
| 137 | MAP3K11 | 0.27366772 |
| 138 | CDK12 | 0.26709102 |
| 139 | GSK3A | 0.26635475 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.83013584 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.61296308 |
| 3 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 2.08050610 |
| 4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.00985948 |
| 5 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.73270348 |
| 6 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.60461435 |
| 7 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.52735858 |
| 8 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.44959329 |
| 9 | Malaria_Homo sapiens_hsa05144 | 1.44344347 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.43891748 |
| 11 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.39542178 |
| 12 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.35252816 |
| 13 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.31688027 |
| 14 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.28915485 |
| 15 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27757970 |
| 16 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27184512 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 1.26468416 |
| 18 | Glioma_Homo sapiens_hsa05214 | 1.25877414 |
| 19 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.24888611 |
| 20 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.24441920 |
| 21 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23470128 |
| 22 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.23128296 |
| 23 | Amoebiasis_Homo sapiens_hsa05146 | 1.22260046 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.21163544 |
| 25 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.20497297 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.20187543 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.20056365 |
| 28 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.14422198 |
| 29 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.12673295 |
| 30 | Focal adhesion_Homo sapiens_hsa04510 | 1.12270014 |
| 31 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.09718369 |
| 32 | Endometrial cancer_Homo sapiens_hsa05213 | 1.09327348 |
| 33 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.08152406 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.07981006 |
| 35 | Salivary secretion_Homo sapiens_hsa04970 | 1.07631425 |
| 36 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.06027926 |
| 37 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.04930541 |
| 38 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.04837026 |
| 39 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.04467850 |
| 40 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.04178573 |
| 41 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.03952122 |
| 42 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.03541948 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.02956041 |
| 44 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.02795406 |
| 45 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.02744704 |
| 46 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.02086865 |
| 47 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.01206188 |
| 48 | Mineral absorption_Homo sapiens_hsa04978 | 0.99513526 |
| 49 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99057397 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.98895627 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.98186178 |
| 52 | Hepatitis B_Homo sapiens_hsa05161 | 0.98133840 |
| 53 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.98069395 |
| 54 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98051131 |
| 55 | Phagosome_Homo sapiens_hsa04145 | 0.96828820 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.96185490 |
| 57 | Leishmaniasis_Homo sapiens_hsa05140 | 0.95982039 |
| 58 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.95443319 |
| 59 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.94302349 |
| 60 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.94180755 |
| 61 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93938713 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.93896239 |
| 63 | Asthma_Homo sapiens_hsa05310 | 0.93564450 |
| 64 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.92713937 |
| 65 | Galactose metabolism_Homo sapiens_hsa00052 | 0.91841500 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.91542783 |
| 67 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91312438 |
| 68 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.90737835 |
| 69 | Bladder cancer_Homo sapiens_hsa05219 | 0.89904264 |
| 70 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.88511648 |
| 71 | Long-term potentiation_Homo sapiens_hsa04720 | 0.87202711 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86322171 |
| 73 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.86046136 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.85638232 |
| 75 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84223537 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.84101849 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.83562071 |
| 78 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83201106 |
| 79 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81574670 |
| 80 | Measles_Homo sapiens_hsa05162 | 0.81473670 |
| 81 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81159299 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.80915215 |
| 83 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.78920504 |
| 84 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.78859570 |
| 85 | Gap junction_Homo sapiens_hsa04540 | 0.78791912 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.78439440 |
| 87 | Tuberculosis_Homo sapiens_hsa05152 | 0.78175064 |
| 88 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.77044449 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.76406927 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.76399282 |
| 91 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76342797 |
| 92 | * Endocytosis_Homo sapiens_hsa04144 | 0.76042323 |
| 93 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.75652371 |
| 94 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.75048363 |
| 95 | Adherens junction_Homo sapiens_hsa04520 | 0.74404395 |
| 96 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.74162213 |
| 97 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.74052589 |
| 98 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73308740 |
| 99 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.72502406 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.72493963 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72117170 |
| 102 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.70502821 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.69138357 |
| 104 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68851999 |
| 105 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.68464173 |
| 106 | Pertussis_Homo sapiens_hsa05133 | 0.67791904 |
| 107 | Apoptosis_Homo sapiens_hsa04210 | 0.67371360 |
| 108 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.67171549 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.65935317 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65073446 |
| 111 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.65013434 |
| 112 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64396635 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.64332243 |
| 114 | Hepatitis C_Homo sapiens_hsa05160 | 0.63674618 |
| 115 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.62428478 |
| 116 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61987377 |
| 117 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.61435594 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.61406888 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.60812142 |
| 120 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60647037 |
| 121 | Cocaine addiction_Homo sapiens_hsa05030 | 0.60450004 |
| 122 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.60374283 |
| 123 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.60125990 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.59974285 |
| 125 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.58473806 |
| 126 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.58181512 |
| 127 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.57871226 |
| 128 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.56681043 |
| 129 | Insulin secretion_Homo sapiens_hsa04911 | 0.56104188 |
| 130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.55525868 |
| 131 | Shigellosis_Homo sapiens_hsa05131 | 0.54908040 |
| 132 | Colorectal cancer_Homo sapiens_hsa05210 | 0.54867451 |
| 133 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.54242602 |
| 134 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53476777 |
| 135 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51171642 |
| 136 | HTLV-I infection_Homo sapiens_hsa05166 | 0.48969360 |
| 137 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.46757678 |

